Yu Xia

Insider Reports History

Location
Zhongshan, Guangdong, China
Signature
/s/ Adam Finerman, as Attorney-in-Fact for Yu Xia
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yu Xia:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Summit Therapeutics Inc. Director Common Stock 32.1M $601M $18.74 21 Oct 2025 Akeso, Inc.
Summit Therapeutics Inc. Director Stock Option (right to buy) 5.44K $49.9K $9.18 02 Jan 2025 Direct

Insider Reports Filed by Yu Xia

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SMMT Summit Therapeutics Inc. 21 Oct 2025 1 $10M 4 Director 23 Oct 2025, 21:06
SMMT Summit Therapeutics Inc. 02 Jan 2025 2 $49.9K 4 Director 06 Jan 2025, 19:24
SMMT Summit Therapeutics Inc. 02 Jan 2024 2 $0 4 Director 04 Jan 2024, 16:19
SMMT Summit Therapeutics Inc. 31 Dec 2023 2 $47.7M 5 Director 14 Feb 2024, 16:35
SMMT Summit Therapeutics Inc. 17 Jan 2023 0 $0 3 Director 26 Jan 2023, 13:48